Canary Cure Therapeutics (Canary Global Inc.) has released preclinical results for its lead candidate, CCT-217, an siRNA therapeutic targeting cannabinoid CB1 receptor (CB1R) and zinc finger protein ...

On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

One common diet question among people taking these drugs, which include Ozempic or Mounjaro for type 2 diabetes and Wegovy or Zepbound for obesity, is: Can I drink on a GLP-1? The short answer is ...

Discover how North Dakota is leading the way by covering Ozempic for weight loss under ACA plans, making it the first U.S.

Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...

Individual plans that are compliant with the Affordable Care Act and are purchased on Healthcare.gov or through a local agent in North Dakota include coverage for glucagon-like peptide-1 (GLP-1 ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Consider restarting zinc acetate treatment based on periodic monitoring of 24-hr urinary copper and NCC levels. Gastric Ulcer: There have been postmarketing reports of gastric ulcers with long-term ...

Developed by Novo Nordisk, semaglutide mimics glucagon-like peptide ... slow gastric emptying time even more than semaglutide alone. Others may sabotage your diet and the benefits of GLP-1 meds.